Rutgers logo
University Finance and Administration

COVID-19

Stories

Laboratory vials

Just one month after Rutgers’ RUCDR Infinite Biologics received Emergency Use Authorization from the Food and Drug Administration (FDA) on April 13, 2020, for its saliva-based COVID-19 test, developed in partnership with Spectrum Solutions and Accurate Diagnostic Labs (ADL), Rutgers University–New Brunswick’s Occupational Health Department would help the university implement a strategic testing program that would govern its efforts to mitigate outbreaks among its more than 24,000 part-time and full-time faculty and staff and its population of 70,000-plus students.

Statue at Rutgers campus

Since COVID-19 led to massive shutdowns around the world last year, the looming cloud of uncertainty has only gotten heavier. Like many organizations, higher education institutions have radically changed. The big questions are: will colleges and universities get back to how we did business pre-pandemic? What is the future of higher education? What roles can people play to navigate through this crisis? 

COVID-19 research

University Procurement Services participated in an innovative, Rutgers-wide coalition to produce personal protective equipment (PPE) and medical device parts for the university’s frontline health care workers currently combating COVID-19. This endeavor, known as the RU 3D PPE project, launched on March 26 and has produced laser-cut face shields and 3D-printed headbands through a network of 40 3D printers at Rutgers facilities.